HORIZON PHARMA PUBLIC LIMITED COMPANY ORDINARY SHARES, NOMINAL VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • November 14th, 2014 • Horizon Pharma PLC • Pharmaceutical preparations • New York
The undersigned understands that Morgan Stanley & Co. LLC, Citigroup Global Markets Inc. and Cowen and Company, LLC, as representatives (together, the “Representatives”) of the several Underwriters, including Morgan Stanley & Co. LLC, Citigroup Global Markets Inc. and Cowen and Company, LLC (the “Underwriters”), propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Horizon Pharma Public Limited Company, a public limited company formed under the laws of Ireland (the “Company”) and certain selling shareholders (the “Selling Shareholders”), providing for the public offering (the “Public Offering”) by the several Underwriters of a number of shares (the “Shares”) of ordinary shares, nominal value $0.0001 per share of the Company (the “Common Stock”).
